Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans

J Clin Oncol. 2008 Apr 1;26(10):1757-9. doi: 10.1200/JCO.2007.14.7330.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Combined Modality Therapy
  • Cytogenetic Analysis*
  • Dermatofibrosarcoma / genetics*
  • Dermatofibrosarcoma / pathology
  • Dermatofibrosarcoma / therapy
  • Female
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Piperazines / therapeutic use
  • Positron-Emission Tomography
  • Pyrimidines / therapeutic use
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate